[Retracted] Prognosis and Therapeutic Efficacy Prediction of Adrenocortical Carcinoma Based on a Necroptosis-Associated Gene Signature

Figure 7

Pathway enrichment analysis and therapeutic response to immunotherapy and chemotherapy in ACC based on the GEO combined cohort. (a) Enrichment analysis of metabolic pathways in the low NAGs group and high NAGs group via GSVA algorithms and comparison of enrichment scores. (b) Tumor immunocyte infiltration landscape of patients in GEO combined cohort. (c) Assessment of therapeutic response to anti-CTLA4 and anti-PD-1 in ACC D. Comparison of response to four chemotherapy agents, including cisplatin, gemcitabine, paclitaxel, and etoposide.

(a)

(b)

(c)

(d)